vs

Side-by-side financial comparison of Invesco (IVZ) and Workday, Inc. (WDAY). Click either name above to swap in a different company.

Workday, Inc. is the larger business by last-quarter revenue ($2.4B vs $1.7B, roughly 1.4× Invesco). Workday, Inc. runs the higher net margin — 10.4% vs -58.9%, a 69.2% gap on every dollar of revenue. On growth, Workday, Inc. posted the faster year-over-year revenue change (12.6% vs 6.2%). Workday, Inc. produced more free cash flow last quarter ($550.0M vs $432.2M). Over the past eight quarters, Workday, Inc.'s revenue compounded faster (12.5% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Workday, Inc. is a leading global enterprise cloud software provider that develops and distributes human capital management, financial management, and enterprise resource planning solutions. It caters primarily to mid-sized and large organizations across sectors including education, healthcare, finance, and technology, with operations spanning North America, Europe, and Asia Pacific.

IVZ vs WDAY — Head-to-Head

Bigger by revenue
WDAY
WDAY
1.4× larger
WDAY
$2.4B
$1.7B
IVZ
Growing faster (revenue YoY)
WDAY
WDAY
+6.4% gap
WDAY
12.6%
6.2%
IVZ
Higher net margin
WDAY
WDAY
69.2% more per $
WDAY
10.4%
-58.9%
IVZ
More free cash flow
WDAY
WDAY
$117.8M more FCF
WDAY
$550.0M
$432.2M
IVZ
Faster 2-yr revenue CAGR
WDAY
WDAY
Annualised
WDAY
12.5%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IVZ
IVZ
WDAY
WDAY
Revenue
$1.7B
$2.4B
Net Profit
$-995.9M
$252.0M
Gross Margin
Operating Margin
-86.2%
10.6%
Net Margin
-58.9%
10.4%
Revenue YoY
6.2%
12.6%
Net Profit YoY
-575.8%
30.6%
EPS (diluted)
$-2.61
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
WDAY
WDAY
Q4 25
$1.7B
$2.4B
Q3 25
$1.6B
$2.3B
Q2 25
$1.5B
$2.2B
Q1 25
$1.5B
$2.2B
Q4 24
$1.6B
$2.2B
Q3 24
$1.5B
$2.1B
Q2 24
$1.5B
$2.0B
Q1 24
$1.5B
$1.9B
Net Profit
IVZ
IVZ
WDAY
WDAY
Q4 25
$-995.9M
$252.0M
Q3 25
$356.4M
$228.0M
Q2 25
$197.4M
$68.0M
Q1 25
$171.1M
$94.0M
Q4 24
$209.3M
$193.0M
Q3 24
$55.0M
$132.0M
Q2 24
$132.2M
$107.0M
Q1 24
$141.5M
$1.2B
Operating Margin
IVZ
IVZ
WDAY
WDAY
Q4 25
-86.2%
10.6%
Q3 25
16.5%
10.6%
Q2 25
14.1%
1.7%
Q1 25
18.1%
3.4%
Q4 24
19.6%
7.6%
Q3 24
6.6%
5.3%
Q2 24
13.9%
3.2%
Q1 24
14.4%
4.1%
Net Margin
IVZ
IVZ
WDAY
WDAY
Q4 25
-58.9%
10.4%
Q3 25
21.7%
9.7%
Q2 25
13.0%
3.0%
Q1 25
11.2%
4.3%
Q4 24
13.1%
8.9%
Q3 24
3.6%
6.3%
Q2 24
8.9%
5.4%
Q1 24
9.6%
61.8%
EPS (diluted)
IVZ
IVZ
WDAY
WDAY
Q4 25
$-2.61
$0.94
Q3 25
$0.66
$0.84
Q2 25
$-0.03
$0.25
Q1 25
$0.38
$0.34
Q4 24
$0.46
$0.72
Q3 24
$0.12
$0.49
Q2 24
$0.29
$0.40
Q1 24
$0.31
$4.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
WDAY
WDAY
Cash + ST InvestmentsLiquidity on hand
$1.0B
$6.8B
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$12.2B
$8.9B
Total Assets
$27.1B
$17.8B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
WDAY
WDAY
Q4 25
$1.0B
$6.8B
Q3 25
$973.1M
$8.2B
Q2 25
$922.7M
$8.0B
Q1 25
$821.7M
$8.0B
Q4 24
$986.5M
$7.2B
Q3 24
$1.0B
$7.4B
Q2 24
$878.5M
$7.2B
Q1 24
$895.7M
$7.8B
Total Debt
IVZ
IVZ
WDAY
WDAY
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
$3.0B
Q1 24
$1.3B
$3.0B
Stockholders' Equity
IVZ
IVZ
WDAY
WDAY
Q4 25
$12.2B
$8.9B
Q3 25
$14.0B
$9.2B
Q2 25
$13.9B
$8.9B
Q1 25
$14.7B
$9.0B
Q4 24
$14.6B
$8.6B
Q3 24
$14.8B
$8.3B
Q2 24
$14.6B
$8.2B
Q1 24
$14.6B
$8.1B
Total Assets
IVZ
IVZ
WDAY
WDAY
Q4 25
$27.1B
$17.8B
Q3 25
$28.4B
$18.0B
Q2 25
$28.5B
$17.2B
Q1 25
$28.1B
$18.0B
Q4 24
$27.0B
$16.4B
Q3 24
$27.5B
$16.2B
Q2 24
$27.2B
$15.9B
Q1 24
$28.1B
$16.5B
Debt / Equity
IVZ
IVZ
WDAY
WDAY
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×
0.37×
Q1 24
0.09×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
WDAY
WDAY
Operating Cash FlowLast quarter
$455.8M
$588.0M
Free Cash FlowOCF − Capex
$432.2M
$550.0M
FCF MarginFCF / Revenue
25.5%
22.6%
Capex IntensityCapex / Revenue
1.4%
1.6%
Cash ConversionOCF / Net Profit
2.33×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$2.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
WDAY
WDAY
Q4 25
$455.8M
$588.0M
Q3 25
$606.2M
$616.0M
Q2 25
$547.9M
$457.0M
Q1 25
$-84.6M
$1.1B
Q4 24
$316.9M
$406.0M
Q3 24
$438.4M
$571.0M
Q2 24
$489.1M
$372.0M
Q1 24
$-54.4M
$995.6M
Free Cash Flow
IVZ
IVZ
WDAY
WDAY
Q4 25
$432.2M
$550.0M
Q3 25
$586.4M
$588.0M
Q2 25
$530.4M
$421.0M
Q1 25
$-108.0M
$1.0B
Q4 24
$309.9M
$359.0M
Q3 24
$410.0M
$516.0M
Q2 24
$462.4M
$291.0M
Q1 24
$-75.4M
$947.6M
FCF Margin
IVZ
IVZ
WDAY
WDAY
Q4 25
25.5%
22.6%
Q3 25
35.7%
25.0%
Q2 25
35.0%
18.8%
Q1 25
-7.1%
46.4%
Q4 24
19.5%
16.6%
Q3 24
27.1%
24.7%
Q2 24
31.2%
14.6%
Q1 24
-5.1%
49.3%
Capex Intensity
IVZ
IVZ
WDAY
WDAY
Q4 25
1.4%
1.6%
Q3 25
1.2%
1.2%
Q2 25
1.2%
1.6%
Q1 25
1.5%
3.9%
Q4 24
0.4%
2.2%
Q3 24
1.9%
2.6%
Q2 24
1.8%
4.1%
Q1 24
1.4%
2.5%
Cash Conversion
IVZ
IVZ
WDAY
WDAY
Q4 25
2.33×
Q3 25
1.70×
2.70×
Q2 25
2.78×
6.72×
Q1 25
-0.49×
11.83×
Q4 24
1.51×
2.10×
Q3 24
7.97×
4.33×
Q2 24
3.70×
3.48×
Q1 24
-0.38×
0.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

WDAY
WDAY

Subscription Services$2.2B92%
Professional Services$188.0M8%

Related Comparisons